Literature DB >> 7851026

Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism.

V A Danis1, M Millington, V J Hyland, D Grennan.   

Abstract

Monocytes from different individuals show variable cytokine production in response to a variety of stimuli. We wished to determine the sets of conditions (cytokine combinations) that would enable us to demonstrate stable inter-individual differences in the production of IL-1 alpha, IL-1 beta, IL-1Ra, on-6 and tumour necrosis factor-alpha (TNF-alpha) by monocytes. We assessed the ability of a number of recombinant human cytokines (granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon-gamma (IFN-gamma), TNF-alpha, IL-4, IL-6, transforming growth factor-beta (TGF-beta), IL-10 and IL-1Ra)) to stimulate or inhibit the production of one or more of these monocyte products. GM-CSF was found to stimulate the production of all five of these cytokines in a highly reproducible manner. TNF-alpha also up-regulated production of IL-1 alpha, IL-1 beta, IL-1Ra and IL-6 by monocytes, but the variability in the results of cells cultured from the same individuals on different occasions was greater. Other cytokines either stimulated production of only some of the five cytokine products tested, or stimulated the production of some cytokine products while inhibiting production of others. This was especially evident when cytokines were used in combination with GM-CSF: IFN-gamma down-regulated production of IL-1Ra while up-regulating the production of IL-1 alpha/beta, IL-6 and TNF-alpha, while IL-4 had the exact opposite effect. Polymorphisms in regions of cytokine genes that affect transcription may account for some of the interindividual variation in cytokine production. We have shown that a stable estimate of cytokine production phenotype can be obtained when monocytes collected on at least two separate occasions are stimulated by GM-CSF in vitro. We have looked for a relationship between IL-1 production and an 86-bp variable repeat polymorphism in intron 2 of the IL-1Ra gene. A less common allele of this polymorphism (allele 2) was associated with increased production of IL-1Ra protein, and also reduced production of IL-1 alpha protein by monocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7851026      PMCID: PMC1534297          DOI: 10.1111/j.1365-2249.1995.tb05549.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level.

Authors:  P Santamaria; R C Gehrz; M K Bryan; J J Barbosa
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

2.  Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor.

Authors:  S Endres; R Ghorbani; G Lonnemann; J W van der Meer; C A Dinarello
Journal:  Clin Immunol Immunopathol       Date:  1988-12

Review 3.  Effects of interleukin 4 on monocyte functions: comparison to interleukin 13.

Authors:  R de Waal Malefyt; C G Figdor; J E de Vries
Journal:  Res Immunol       Date:  1993-10

4.  Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist.

Authors:  J C Mansfield; H Holden; J K Tarlow; F S Di Giovine; T L McDowell; A G Wilson; C D Holdsworth; G W Duff
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

5.  A highly polymorphic locus in human DNA.

Authors:  A R Wyman; R White
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

6.  Reversible silencing of enhancers by sequences derived from the human IFN-alpha promoter.

Authors:  D Kuhl; J de la Fuente; M Chaturvedi; S Parimoo; J Ryals; F Meyer; C Weissmann
Journal:  Cell       Date:  1987-09-25       Impact factor: 41.582

7.  Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences.

Authors:  J Mølvig; L Baek; P Christensen; K R Manogue; H Vlassara; P Platz; L S Nielsen; A Svejgaard; J Nerup
Journal:  Scand J Immunol       Date:  1988-06       Impact factor: 3.487

8.  Interleukin-1 secretion by peripheral blood monocytes and synovial macrophages from patients with rheumatoid arthritis.

Authors:  V A Danis; L M March; D S Nelson; P M Brooks
Journal:  J Rheumatol       Date:  1987-02       Impact factor: 4.666

9.  Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions.

Authors:  W D Xu; G S Firestein; R Taetle; K Kaushansky; N J Zvaifler
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

10.  Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells.

Authors:  M Muzio; F Re; M Sironi; N Polentarutti; A Minty; D Caput; P Ferrara; A Mantovani; F Colotta
Journal:  Blood       Date:  1994-04-01       Impact factor: 22.113

View more
  97 in total

1.  Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1beta after live yellow fever vaccination.

Authors:  U T Hacker; S Erhardt; K Tschöp; T Jelinek; S Endres
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

2.  Genetics of the bone response to bisphosphonate treatments.

Authors:  Francesco Massart; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

Review 3.  Understanding rheumatic fever.

Authors:  Pedro Ming Azevedo; Rosa Rodrigues Pereira; Luiza Guilherme
Journal:  Rheumatol Int       Date:  2011-09-28       Impact factor: 2.631

4.  Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers.

Authors:  L Joos; L McIntyre; J Ruan; J E Connett; N R Anthonisen; T D Weir; P D Paré; A J Sandford
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

5.  IL-1 family members as candidate genes modulating scrapie susceptibility in sheep: localization, partial characterization, and expression.

Authors:  Ane Marcos-Carcavilla; Jorge H Calvo; Carmen González; Katayoun Moazami-Goudarzi; Pascal Laurent; Maud Bertaud; Hélène Hayes; Anne E Beattie; Carmen Serrano; Jaber Lyahyai; Inmaculada Martín-Burriel; Estefânia Alves; Pilar Zaragoza; Juan J Badiola; Magdalena Serrano
Journal:  Mamm Genome       Date:  2007-01-22       Impact factor: 2.957

6.  Effect of serum interleukin-1 receptor antagonist level on survival of patients with non-small cell lung cancer.

Authors:  Murat Yigit; Serkan Değirmencioğlu; Erhan Ugurlu; Arzu Yaren
Journal:  Mol Clin Oncol       Date:  2017-03-15

Review 7.  Cytokine polymorphisms in silicosis and other pneumoconioses.

Authors:  Berran Yucesoy; Val Vallyathan; Douglas P Landsittel; Petia Simeonova; Michael I Luster
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

8.  Allelic variation at the interleukin 1beta gene is associated with decreased bone mass in patients with inflammatory bowel diseases.

Authors:  A Nemetz; M Tóth; M A García-González; T Zágoni; J Fehér; A S Peña; Z Tulassay
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

9.  The course of gastric cancer following surgery is associated with genetic variations of the interleukin-1 receptor antagonist and interleukin-1β.

Authors:  Anke H van der Ploeg; Oliver Kumpf; Evelyn Seelow; Luis C Berrocal Almanza; Peter M Schlag; Ralf R Schumann; Lutz Hamann
Journal:  Gastric Cancer       Date:  2014-02-21       Impact factor: 7.370

10.  Autoreactive Th1 cells activate monocytes to support regional Th17 responses in inflammatory arthritis.

Authors:  Donald M Simons; Soyoung Oh; Elizabeth Kropf; Malinda Aitken; Victoria Garcia; Alissa Basehoar; Andrew J Caton
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.